11th Tysabri Patient Develops PML
Links shared publicly online about this topic.
- 1,862total visits
11th Tysabri Patient Develops PML
View full resource at medicalnewstoday.com
Tags: Brain, Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Tysabri, Biogen Idec
Most Recently Shared on July 29, 2009 at 1:34 pm By:
MedNewsToday: 11th Tysabri Patient Develops PML: An 11th patient taking Biogen Idec's multiple scle.. http://bit.ly/18aQHf
Brass and Ivory: Life with MS & RA: Tysabri-related PML Death Cases Total 29 in July 2011
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on July 15, 2011 at 10:51 pm By:
Tysabri-related PML Cases Total 29 in July 2011: Five more patients who had developed PML after using Tysabri ha... http://bit.ly/na2Ek3
Unilabs Announces Alliance in Companion Diagnostic Testing with Biogen Idec | IVD Technology
ivdtechnology.com — “Unilabs has been selected by Biogen Idec to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV. The test is a two-step ELISA assay used to detect anti-JCV antibodies. The presence of anti-JCV antibodies is one in a three-factor risk stratification algorithm, along with prior immunosuppressant use and treatment duration, used to calculate the risk of TYSABRI-treated patients developing progressive multifocal leukoencephalopathy (PML).” View full resource at ivdtechnology.com
Most Recently Shared on July 6, 2011 at 7:05 pm By:
IVD Technology Health Magazine
Unilabs Announces Alliance in Companion Diagnostic Testing with Biogen Idec http://tinyurl.com/3nduc3t
Survival in MS-based PML Improves, But Disability Still High (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at qualitypointtech.net
Most Recently Shared on May 22, 2011 at 6:00 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dr... http://bit.ly/mAD2Tr
Medical News: Survival in MS-based PML Improves, But Disability Still High - in Neurology, General Neurology from MedPage Today
medpagetoday.com — “Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at medpagetoday.com
Most Recently Shared on May 22, 2011 at 5:07 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dramat.. http://dld.bz/aaTgx
Biogen reports four more Tysabri cases, one death | Reuters
reuters.com — “NEW YORK (Reuters) - Four more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed the serious brain infection known as PML and one of them died, according to the biotechnology” View full resource at reuters.com
Most Recently Shared on December 17, 2010 at 9:49 pm By:
Hisham Rana, MD Doctor and Physician
News: Biogen reports 4 new cases of potentially fatal progressive multifocal leukoencephalopathy http://reut.rs/hsf0aU - #health
Biogen discloses PML cases, one death in Tysabri patients - FiercePharma
fiercepharma.com — “Four more patients taking Biogen Idec's multiple sclerosis drug Tysabri have developed the serious brain infection known as progressive multifocal leukoencephalopathy (PML), and one of them died,... Read more...” View full resource at fiercepharma.com
Most Recently Shared on December 17, 2010 at 2:17 pm By:
Biogen discloses PML cases, one death in Tysabri patients. http://bit.ly/eFMIoL
Biogen reports more brain infections in MS patients | Reuters
reuters.com — “BOSTON (Reuters) - Two more patients taking Biogen Idec Inc's multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company said on Wednesday. The Cambridge,” View full resource at reuters.com
Most Recently Shared on October 21, 2010 at 8:15 pm By:
Hisham Rana, MD Doctor and Physician
News: Biogen reports more brain infections in MS patients http://reut.rs/c0jCsJ - Progressive multifocal leukoencephalopathy (PML) #health
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy - MPR
empr.com — “The FDA has notified healthcare professionals and patients that the risk of developing progressive multifocal leukoencephalopathy (PML) increases with the number of Tysabri (natalizumab, from Biogen Idec) infusions received.” View full resource at empr.com
Most Recently Shared on February 5, 2010 at 6:44 pm By:
MPR News: Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy: Th... http://bit.ly/9G7EQr
Eugene Major, PhD: JC virus levels and the risk for PML with Tysabri | CurrentMedicine.tv
currentmedicine.tv — “Normal 0 The HCC interviewed the Chief of the labs at the NIH that tests samples of patients who develop PML while on Tysabri, Dr. Major. This lab” View full resource at currentmedicine.tv
Most Recently Shared on September 30, 2009 at 4:28 pm By:
Healthcare Channel Health Site
New Video: The NIH discusses that safety of multiple sclerosis patients on Tysabri http://tinyurl.com/yzkua89 BIIB ELN
Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought
medicalnewstoday.com — “The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much ” View full resource at medicalnewstoday.com
Most Recently Shared on May 8, 2009 at 2:37 pm By:
MedNewsToday: Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought: Th.. http://tinyurl.com/re7kp3
Advertisement
